NPS Pharma (NPSP) Misses Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts NPSP Hot Sheet
Price: $45.97 --0%
Financial Fact:
Research and development: 24.53M
Today's EPS Names:
SODI, PGR, OMID, More
Financial Fact:
Research and development: 24.53M
Today's EPS Names:
SODI, PGR, OMID, More
Join SI Premium – FREE
NPS Pharma (NASDAQ: NPSP) reported Q4 EPS of ($0.02), $0.08 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $66.7 million versus the consensus estimate of $69.3 million.
For earnings history and earnings-related data on NPS Pharma (NPSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman’s CEO Solomon says to watch political volatility around data centers
- IREN shares drop as Anthropic deal enthusiasm fades
- S&P upgrades Kioxia to BBB on strong AI-driven growth and upbeat outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
